VRCA
Verrica Pharmaceuticals Inc
4.20$
+1.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -507.7% | -729.7% | -521.4% | -316.0% | – | -4,669.8% | -368.6% | -79.1% | 67.5% | -90.2% | -182.4% | -158.3% | -44.0% | |
| 7.2% | 10.9% | 8.9% | 6.5% | – | 73.5% | 6.0% | 0.9% | 1.3% | 3.4% | 3.9% | 3.5% | 2.5% | |
| 331.3% | 104.4% | 54.2% | 43.0% | – | 219.8% | 29.8% | 7.0% | 5.0% | 13.5% | 17.9% | 20.7% | 11.6% | |
| -9.6% | 244.8% | -65.6% | -46.2% | – | -1,189.2% | -133.4% | -91.4% | 55.3% | 39.4% | -40.2% | -10.9% | 24.0% | |
| 2.2% | 11.4% | 0.0% | 0.2% | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -2.2% | -11.4% | – | -0.2% | – | 2.3% | – | – | – | – | – | – | – | |
| – | -0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -440.1% | -118.0% | -32.7% | -27.8% | -707.1% | -2.2% | -2.1% | -132.7% | |
| 1,509.9% | -1.4% | -17.3% | -12.4% | – | 11,461.0% | -118.0% | -32.7% | -27.8% | 267.9% | -2.4% | -2.1% | 31.0% | |
| 999.9% | -742.5% | -538.6% | -328.5% | – | 6,793.6% | -486.6% | -111.8% | 39.7% | 177.7% | -190.1% | -155.9% | -13.0% | |
| -510.0% | -741.1% | -521.4% | -316.2% | – | -4,669.8% | -368.6% | -79.1% | 67.5% | -90.2% | -182.4% | -158.3% | -44.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.